Peri-exercise co-ingestion of branched-chain amino acids and carbohydrate in men does not preferentially augment resistance exercise-induced increases in PI3K/Akt-mTOR pathway markers indicative of muscle protein synthesis

The effects of a single bout of resistance exercise (RE) in conjunction with peri-exercise branched chain amino acid (BCAA) and carbohydrate (CHO) ingestion on skeletal muscle signaling markers indicative of muscle protein synthesis (MPS) were determined. It was hypothesized that CHO + BCAA would elicit a more profound effect on these signaling markers compared to CHO. Twenty-seven males were randomly assigned to CHO, CHO + BCAA, or placebo (PLC) groups. Four sets of leg presses and leg extensions were performed at 80% 1RM. Supplements were ingested 30 min and immediately prior to and after RE. Venous blood and muscle biopsy samples were obtained immediately prior to supplement ingestion and 0.5 hr, 2 hr, and 6 hr after RE. Serum insulin and glucose and phosphorylated levels of muscle insulin receptor substrate 1 (IRS1), protein kinase B (Akt), mammalian target of rapamycin (mTOR), p70S6 kinase (p70S6K), and 4E binding protein 1 (4E-BP1) were assessed. Data were analyzed by two-way repeated measures ANOVA. Significant group x time interactions were observed for glucose and insulin (p \u3c 0.05) showing that CHO and CHO + BCAA were significantly greater than PLC. Significant time main effects were observed for IRS1 (p = 0.001), Akt (p = 0.031), mTOR (p = 0.003), and p70S6K (p = 0.001). CHO and CHO + BCAA supplementation significantly increased IRS-1 compared to PLC (p = 0.002). However, peri-exercise co-ingestion of CHO and BCAA did not augment RE-induced increases in skeletal muscle signaling markers indicative of MPS when compared to CHO

Effects of ingesting protein with various forms of carbohydrate following resistance-exercise on substrate availability and markers of anabolism, catabolism, and immunity

<p>Abstract</p> <p>Background</p> <p>Ingestion of carbohydrate (CHO) and protein (PRO) following intense exercise has been reported to increase insulin levels, optimize glycogen resynthesis, enhance PRO synthesis, and lessen the immuno-suppressive effects of intense exercise. Since different forms of CHO have varying glycemic effects, the purpose of this study was to determine whether the type of CHO ingested with PRO following resistance-exercise affects blood glucose availability and insulin levels, markers of anabolism and catabolism, and/or general immune markers.</p> <p>Methods</p> <p>40 resistance-trained subjects performed a standardized resistance training workout and then ingested in a double blind and randomized manner 40 g of whey PRO with 120 g of sucrose (S), honey powder (H), or maltodextrin (M). A non-supplemented control group (C) was also evaluated. Blood samples were collected prior to and following exercise as well as 30, 60, 90, and 120 min after ingestion of the supplements. Data were analyzed by repeated measures ANOVA or ANCOVA using baseline values as a covariate if necessary.</p> <p>Results</p> <p>Glucose concentration 30 min following ingestion showed the H group (7.12 ± 0.2 mmol/L) to be greater than S (5.53 ± 0.6 mmol/L; p < 0.03); M (6.02 ± 0.8 mmol/L; p < 0.05), and C (5.44 ± 0.18 mmol/L; p < 0.0002) groups. No significant differences were observed among groups in glucose area under the curve (AUC) values, although the H group showed a trend versus control (p = 0.06). Insulin response for each treatment was significant by time (p < 0.0001), treatment (p < 0.0001) and AUC (p < 0.0001). 30-min peak post-feeding insulin for S (136.2 ± 15.6 <it>u</it>IU/mL), H (150.1 ± 25.39 <it>u</it>IU/mL), and M (154.8 ± 18.9 <it>u</it>IU/mL) were greater than C (8.7 ± 2.9 <it>u</it>IU/mL) as was AUC with no significant differences observed among types of CHO. No significant group × time effects were observed among groups in testosterone, cortisol, the ratio of testosterone to cortisol, muscle and liver enzymes, or general markers of immunity.</p> <p>Conclusion</p> <p>CHO and PRO ingestion following exercise significantly influences glucose and insulin concentrations. Although some trends were observed suggesting that H maintained blood glucose levels to a better degree, no significant differences were observed among types of CHO ingested on insulin levels. These findings suggest that each of these forms of CHO can serve as effective sources of CHO to ingest with PRO in and attempt to promote post-exercise anabolic responses.</p

Effects of Beta-Alanine on Muscle Carnosine and Exercise Performance:A Review of the Current Literature

Muscle carnosine has been reported to serve as a physiological buffer, possess antioxidant properties, influence enzyme regulation, and affect sarcoplasmic reticulum calcium regulation. Beta-alanine (β-ALA) is a non-essential amino acid. β-ALA supplementation (e.g., 2-6 grams/day) has been shown to increase carnosine concentrations in skeletal muscle by 20-80%. Several studies have reported that β-ALA supplementation can increase high-intensity intermittent exercise performance and/or training adaptations. Although the specific mechanism remains to be determined, the ergogenicity of β-ALA has been most commonly attributed to an increased muscle buffering capacity. More recently, researchers have investigated the effects of co-ingesting β-ALA with creatine monohydrate to determine whether there may be synergistic and/or additive benefits. This paper overviews the theoretical rationale and potential ergogenic value of β-ALA supplementation with or without creatine as well as provides future research recommendations

Bioactive properties and clinical safety of a novel milk protein peptide

Milk protein fractions and peptides have been shown to have bioactive properties. This preliminary study examined the potential mechanisms of action and clinical safety of novel milk protein peptide (MP). A novel MP mixture inhibits the tyrosine kinase activity of epidermal growth factor receptor (EGFR), vascular endothelial growth factor receptor 2 (VEGFR2), and insulin receptor (IR) with IC50 of 9.85 μM, 7.7 μM, and 6.18 μM respectively. In vitro, this multi-kinase inhibitor causes apoptosis in HT-29 colon cancer cells, and in a C. elegans worm study, showed a weak but significant increase in lifespan. A six week double-blind, placebocontrolled study involving 73 healthy volunteers demonstrated that the MP mixture is safe to consume orally. All clinical blood markers remained within normal levels and no clinically significant side effects were reported. There was some evidence of improved insulin sensitivity, neutrophil-to-lymphocyte ratio (NLR), and quality of life assessment of role of physical function. These data in combination with the observed in vitro anti-cancer properties warrant further clinical studies to investigate this MP mixture as a potential clinical nutrition intervention for improving the quality of life and clinical outcomes in cancer patients

The effects of age on skeletal muscle and the phosphocreatine energy system: can creatine supplementation help older adults

Creatine supplementation has been found to significantly increase muscle strength and hypertrophy in young adults (≤ 35 yr) particularly when consumed in conjunction with a resistance training regime. Literature examining the efficacy of creatine supplementation in older adults (55-82 yr) suggests creatine to promote muscle strength and hypertrophy to a greater extent than resistance training alone. The following is a review of literature reporting on the effects of creatine supplementation on intramuscular high energy phosphates, skeletal muscle morphology and quality of life in older adults. Results suggest creatine supplementation to be a safe, inexpensive and effective nutritional intervention, particularly when consumed in conjunction with a resistance training regime, for slowing the rate of muscle wasting that is associated with aging. Physicians should strongly consider advising older adults to supplement with creatine and to begin a resistance training regime in an effort to enhance skeletal muscle strength and hypertrophy, resulting in enhanced quality of life

Co-ingestion of carbohydrate with branched-chain amino acids or L-leucine does not preferentially increase serum IGF-1 and expression of myogenic-related genes in response to a single bout of resistance exercise

This study determined if the co-ingestion of carbohydrate (CHO) with branched-chain amino acids (BCAA) or L-leucine (LEU) preferentially affected serum IGF-1 and the expression of myogenic-related genes in response to resistance exercise (RE). Forty one, college-age males were randomly assigned to 1 of 4 groups: CHO, CHO-BCAA, CHO-LEU, or placebo (PLC). Resistance exercise consisted of 4 sets of leg press and leg extension at 80% 1RM. Supplements were ingested peri-exercise, and venous blood and muscle biopsies were obtained pre-exercise (PRE), and at 30, 120, and 360 min post-exercise. Serum IGF-1 was determined with ELISA, and skeletal muscle mRNA expression of myostatin, ActRIIB, p21kip, p27kip, CDK2, cyclin B1, cyclin D1, Myo-D, myogenin, MRF-4, and myf5 was determined using real-time PCR. Results were determined with two-way ANOVA for serum IGF-1 and two-way MANOVA for mRNA expression. Serum IGF-1 in CHO and CHO+BCAA was greater than PLC (p \u3c 0.05) but was not affected by RE (p \u3e 0.05). Significant differences were detected between groups for myostatin, ActIIB, MyoD, and myf5 mRNA expression showing CHO to be significantly different than CHO+BCAA, CHO+LEU, and PLC (p \u3c 0.05). At 30, 120 and 360 min post-exercise, p21cip was significantly less than PRE, whereas cyclin D1 was greater than PRE at 120 and 360 min post-exercise (p \u3c 0.05). The co-ingestion of CHO with either BCAA or L-leucine in conjunction with RE had no preferential effect on serum IGF-1 or pre-translational markers indicative of myogenesis

The role of exercise training on lipoprotein profiles in adolescent males

BACKGROUND: Major cardiovascular disorders are being recognized earlier in life. In this study we examined the effects of swimming and soccer training on male adolescent lipid-lipoprotein profiles relative to a maturity matched control group to determine the effects of these exercises on specific cardiovascular risk and anti-risk factors. METHODS: Forty five adolescent males (11.81 ± 1.38 yr) including swimmers (SW), soccer players (SO), and non-athlete, physically active individuals as controls (C), participated in this study. Training groups completed 12-wk exercise programs on three non-consecutive days per week. Plasma low-density lipoprotein (LDL), very low density lipoprotein (VLDL), high density lipoprotein (HDL), apolipoprotein A-I (apoA-I), apolipoprotein B (apoB), total cholesterol (TC), and triglyceride (TG) levels were measured in control, pre-training, during-training, and post-training. RESULTS: In response to the 12-wk training period, the SO group demonstrated a decrease in the mean LDL level compared to the SW and C (SW: 0.15%; SO: −9.51%; C: 19.59%; p < 0.001) groups. There was an increase in both the SW and SO groups vs. the control in mean HDL (SW: 5.66%; SO: 3.07%; C: −7.21%; p < 0.05) and apoA-I (SW: 3.86%; SO: 5.48%; C: −1.01%; p < 0.05). ApoB was considerably lower in the training groups vs. control (SW: −9.52%; SO: −13.87%; C: 21.09%; p < 0.05). ApoA-I/apoB ratio was significantly higher in training groups vs. control (SW: 16.74%; SO: 23.71%; C: −17.35%; p < 0.001). There were no significant differences between groups for other factors. CONCLUSIONS: The favorable alterations in LDL, HDL, apoA-I, and apoB observed in the training groups suggest that both regular swimming or soccer exercise can potentially mitigate cardiovascular risk in adolescent males

Bioactive Properties and Clinical Safety of a Novel Milk Protein Peptide

Background: Milk protein fractions and peptides have been shown to have bioactive properties. This preliminary study examined the potential mechanisms of action and clinical safety of novel milk protein peptide ( MP). Findings: A novel MP mixture inhibits the tyrosine kinase activity of epidermal growth factor receptor ( EGFR), vascular endothelial growth factor receptor 2 (VEGFR2), and insulin receptor (IR) with IC(50) of 9.85 mu M, 7.7 mu M, and 6.18 mu M respectively. In vitro, this multi-kinase inhibitor causes apoptosis in HT-29 colon cancer cells, and in a C. elegans worm study, showed a weak but significant increase in lifespan. A six week double-blind, placebo-controlled study involving 73 healthy volunteers demonstrated that the MP mixture is safe to consume orally. All clinical blood markers remained within normal levels and no clinically significant side effects were reported. There was some evidence of improved insulin sensitivity, neutrophil-to-lymphocyte ratio (NLR), and quality of life assessment of role of physical function. Conclusions: These data in combination with the observed in vitro anti-cancer properties warrant further clinical studies to investigate this MP mixture as a potential clinical nutrition intervention for improving the quality of life and clinical outcomes in cancer patients

Muscle fiber and performance adaptations to resistance exercise with MyoVive, colostrum or casein and whey supplementationa

This is the publisher's version, also found at http://ehis.ebscohost.com/ehost/detail?sid=ba69ee0d-97cf-4a2c-a1a2-2c26fb60d65c%40sessionmgr13&vid=1&hid=2&bdata=JnNpdGU9ZWhvc3QtbGl2ZQ%3d%3d#db=s3h&AN=10725638To determine the effects of 12 weeks of resistance exercise with MyoVive and/or colostrum supplementation, 19 male and female recreationally weighttrained subjects (X ± SE; age = 28.3 ± 6.9 yrs; hgt = 68.2 ± 3.8 cm) were divided into MyoVive + colostrum (n = 4), MyoVive + casein & whey (n = 4), colostrum + casein & whey (n = 6), and casein & whey (n = 5) groups. All groups similarly increased (p < .05) 1 repetition maximum (RM) leg press (kg; pre = 158.6 ± 12.8, post = 189.3 ± 11.3), body mass (kg; pre = 79.0 ± 3.2, post = 80.7 ± 3.8), and lean body mass (kg; pre = 60.1 ± 3.1, post = 62.2 ± 2.8). Increases were observed for peak force (N; all loads), peak velocity (m.s-1; 70% & 40% 1 RM), and peak power (W; 70% & 40% 1 RM) for all groups for the leg press exercise, with no differences between groups. When performance data were adjusted for body mass, lean body mass, lower body lean mass as determined by DEXA, or % change, no group differences were observed. Relative (%) fiber type content, cross-sectional areas (mm2), % fiber type areas, or % myosin heavy chain expression did not change for any group. These data suggest that MyoVive and colostrum supplementation have no greater effect on cellular and performance adaptations when compared to casein and whey protein